Search 

Hanriver Capital is a fund management company focusing on life science industry. The core team members are made up of top investment management company executives and CRO company executives. We invest in bil drugs, anti-aging, assisted reproduction and other high-quality projects at home and abroad.

Health & Life Science Cluster Bulgaria (www.biocluster.bg) has been founded three years ago to unify the efforts of experts, scientists, practitioners, researchers, academic institutions, startups, globally established companies, incubators, technology transfer companies, journalists, marketing and PR experts, who work for the advancement of biotechnology and life sciences field in Bulgaria.

The cluster successfully partners with a number of institutions and organizations, including Ministry of Economic, Ministry of education, BSMEPA, Sofia Municipality, Stara Zagora Municipality, Varna local authorities, Sofia Tech Park, BCCI, BESCO, Bulgarian Investment Agency, Medical University of Plovdiv, Medical University of Varna, Trakia University in Stara Zagora, CFA Bulgaria, EEN, Premium coworking spaces, PARA, United drone society, and many others.

The cluster participates in the establishment and the Management Board of the Association Bioscientific Society Bulgaria, which aims to support the development of the biosciences in Bulgaria and consolidation of a unified society of representatives of the Bulgarian bioscience community, working and studying both within Bulgaria and abroad. The cluster is a member of the Board of BRAIT (Bulgarian Employers' Association for Innovation and Technology, which is legal successor of the Bulgarian cluster association), together with Automotive Cluster, Mechatronics Cluster, BAIT, BASCOM, ICT Cluster and others.

The founding members of the cluster are into the core of the creation of The AI Cluster Bulgaria (www.aicluster.bg) in order to stimulate and create high value cross industry projects.

One of the objectives of the cluster is to stimulate, validate and promote technological progress in the sector of health & life sciences, as well as to connect scientists with business leaders, academia and media. Therefor Club Biotechnology & Life Sciences was founded at the beginning of 2020 in a collaboration with Sofia Tech Park.

The Cluster focuses its efforts on the development of a technology program at all levels: regional, national, and international.

Taifeng Group is a nationwide company, located in Henan province, focus on the medical industry in China. The company was established in 2005 and gradually formed a two-medicine model with both“Chinese and Western medicine research and development, manufacturing, and sales”. We developed a modern Taifeng Characteristic medicine system.

We are into Mabs - Biosimilars

Hong Kong Biotechnology Organization is an independent nonprofit organization with the goal to promote best practice, raise awareness across the biotechnology industry while providing added value benefits to its members, whether they are students, researchers, entrepreneurs, industry bodies, public or private sector representatives.

Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in research and development, engineering and business. Hong Kong Biotechnology Organization aims to establish and facilitate a worldwide platform for the Hong Kong biotech industry, promote awareness, encouraging and enabling international collaboration. We also provide informed opinion and technical advice to government bodies, healthcare institutions and the general public.

PE/VC firm

Humanwell is the market leader in anaesthetics/analgesics, fertility regulation drugs, and Uyghur medicine in Asia. It is also a major player with expanding product portfolio and market shares in treating central nerve system, respiratory and dermatological diseases in China.

We are a clinical stage biopharma company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders

Founded in June 2019, with a focus on high-performance medical devices, the Innovation Center of High-Performance Medical Device is devoted to boosting collaboration as well as in-depth integration and innovation of the "Clinical Practice - Scientific Research - Industry - Market"
ecosystem to build high-quality industrial clusters of medical devices by aggregating and utilizing the innovation resources of the Guangdong-Hong Kong-Macao Greater Bay Area and also international resources based on solid clinical practice and industrial basis of Guangdong Province.

Illumina is a provider of Next Generation Sequencing technology